News
RNAZ
1.690
+2.42%
0.040
TransCode Therapeutics Announces Australia Acceptance Of Patent application, Japan's Issuance Of Notice Of Allowance For Its RNA-Based Therapeutic Platform Technologies
Benzinga · 4d ago
Weekly Report: what happened at RNAZ last week (0914-0918)?
Weekly Report · 5d ago
Weekly Report: what happened at RNAZ last week (0907-0911)?
Weekly Report · 09/14 09:21
TransCode Therapeutics Announces CFO Resignation and Interim Appointment
TipRanks · 09/11 21:26
TransCode Therapeutics Taps Tattory to Be Interim CFO
Dow Jones · 09/10 21:36
TransCode Therapeutics CFO retires
Seeking Alpha · 09/10 20:23
TransCode Therapeutics, CFO Tom Fitzgerald Plans To Retire; John Tattory To Serve As Interim Finance Chief, Effective Immediately
Benzinga · 09/10 20:22
Transcode Therapeutics CFO Fitzgerald retiring, Tattory named interim CFO
TipRanks · 09/10 20:20
*Transcode Therapeutics: Fitzgerald Will Continue to Provide Transition Services >RNAZ
Dow Jones · 09/10 20:17
*Transcode Therapeutics: John Tattory to Become Interim Chief Fincl Officer >RNAZ
Dow Jones · 09/10 20:16
*Transcode Therapeutics: Fitzgerald Will Resign as CFO and as a Director, Effective Immediately >RNAZ
Dow Jones · 09/10 20:16
*Transcode Therapeutics: Tom Fitzgerald, Chief Fincl Officer, to Retire
Dow Jones · 09/10 20:16
Press Release: TransCode Therapeutics Announces Leadership Transition
Dow Jones · 09/10 20:10
Weekly Report: what happened at RNAZ last week (0831-0904)?
Weekly Report · 09/07 09:20
Transcode Therapeutics announces publication of article on TTX-MC138
TipRanks · 08/31 12:15
TransCode Therapeutics Announces Publication Demonstrating Survival Benefit of TTX-MC138 in Preclinical Model of Breast Cancer Bone Metastasis
PR Newswire · 08/31 12:05
Weekly Report: what happened at RNAZ last week (0824-0828)?
Weekly Report · 08/31 09:22
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 08/28 21:06
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 08/27 21:07
Weekly Report: what happened at RNAZ last week (0817-0821)?
Weekly Report · 08/24 09:22
More
Webull provides a variety of real-time RNAZ stock news. You can receive the latest news about Transcode Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About RNAZ
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. It is defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. Its lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a biomarker of metastasis. The Company is also developing a portfolio of RNA therapeutic candidates to overcome delivery challenges and unlock access to novel genetic targets. Its preclinical programs include TTX-siPDL1 (siRNA modulator of PD-L1), TTX-RIGA (RNA agonist of RIG-I for innate immunity activation), and TTX-siMYC (siRNA inhibitor of c-MYC). Additionally, R&D efforts are exploring the combination of TTX-MC138 and seviprotimut-L technologies to enhance therapeutic impact.